These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10530780

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rat lung peroxiredoxins I and II are differentially regulated during development and by hyperoxia.
    Kim HS, Kang SW, Rhee SG, Clerch LB.
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1212-7. PubMed ID: 11350800
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Complementary regulation of heme oxygenase-1 and peroxiredoxin I gene expression by oxidative stress in the liver.
    Immenschuh S, Fahimi HD, Baumgart-Vogt E.
    Cell Mol Biol (Noisy-le-grand); 2005 Oct 03; 51(5):471-7. PubMed ID: 16309569
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system.
    Kim JA, Park S, Kim K, Rhee SG, Kang SW.
    Anal Biochem; 2005 Mar 15; 338(2):216-23. PubMed ID: 15745741
    [Abstract] [Full Text] [Related]

  • 30. Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines.
    Chaudhary A, Pechan T, Willett KL.
    Toxicol Appl Pharmacol; 2007 Apr 15; 220(2):197-210. PubMed ID: 17292933
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Overexpression of peroxiredoxin in human breast cancer.
    Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ.
    Anticancer Res; 2001 Apr 15; 21(3B):2085-90. PubMed ID: 11497302
    [Abstract] [Full Text] [Related]

  • 34. Hyperoxidation of Peroxiredoxins: Gain or Loss of Function?
    Veal EA, Underwood ZE, Tomalin LE, Morgan BA, Pillay CS.
    Antioxid Redox Signal; 2018 Mar 01; 28(7):574-590. PubMed ID: 28762774
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Peroxiredoxin VI in human respiratory system.
    Chuchalin AG, Novoselov VI, Shifrina ON, Soodaeva SK, Yanin VA, Barishnikova LM.
    Respir Med; 2003 Feb 01; 97(2):147-51. PubMed ID: 12587965
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Selenoenzymes, laboratory parameters, and trace elements in different types of thyroid tumor.
    Zagrodzki P, Nicol F, Arthur JR, Słowiaczek M, Walas S, Mrowiec H, Wietecha-Posłuszny R.
    Biol Trace Elem Res; 2010 Apr 01; 134(1):25-40. PubMed ID: 19597722
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunohistochemical assessment of peroxidase-like immunoreactivity in the thyroid gland and its correlation with biochemical assay.
    Carlei F, Schietroma M, Ventura T, Risetti A, Casciani G, Mattucci S, Baschieri I, Lezoche E, Simi M.
    Minerva Chir; 1998 Jun 01; 53(6):511-4. PubMed ID: 9774843
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.